Any changes to law on human gene editing should be after public consultation
By Peter McKnight,
Vancouver Sun
| 12. 08. 2022
When a scientist announces the opening of a new laboratory, it doesn’t ordinarily make news around the world. But Chinese biophysicist He Jiankui is no ordinary scientist.
He’s announcement at the end of November came just seven months after he completed a three-year prison sentence for practising medicine illegally. At issue was He’s 2018 YouTube announcement that he had created the world’s first gene-edited babies.
As details became clear, scientists and lawmakers inside and outside China condemned He’s actions, and he was ultimately fired, fined and sentenced to prison. Gene editing also received a lot of negative press, with the usual stories about designer babies flooding the media. He’s new announcement could result in a repeat of the hysteria.
Indeed, stories raising the spectre of eugenics led Canada to prohibit human gene editing long before He created his designer babies. He employed a technique known as CRISPR, short for clustered regularly interspaced short palindromic repeats, which acts like a pair of scissors that allows scientists to edit parts of the human genome.
He used CRISPR to edit the genes of...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...